Last reviewed · How we verify
Low Molecular Weight Heparin
Low Molecular Weight Heparin is a Small molecule drug developed by Yangzhou University. It is currently FDA-approved. Also known as: Fraxiparine, tinzaparin, Innohep LEO pharmaceutical products, heparin.
At a glance
| Generic name | Low Molecular Weight Heparin |
|---|---|
| Also known as | Fraxiparine, tinzaparin, Innohep LEO pharmaceutical products, heparin, Nadroparin calcium |
| Sponsor | Yangzhou University |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Effect of Anticoagulant Therapy on Endometrial Receptivity and Pregnancy Outcomes in Infertility
- Ultrasound-facilitated, Catheter-directed, Thrombolysis in Intermediate-high Risk Pulmonary Embolism (PHASE4)
- Epunamin Combined With DECP for Relapsed/Refractory Multiple Myeloma
- Timing of Venous Thromboembolism Prophylaxis in Patients With Hypertensive Intracerebral Hemorrhage (NA)
- Efficacy of Apixaban in the Treatment of Portal Vein Thrombosis Occurring More Than One Year After LS (NA)
- Dose-adjustment of Enoxaparin by a Bayesian Pharmacological Approach in Pediatric Kidney Transplant Recipients (OPTI-TREX) (PHASE4)
- Dabigatran vs. Oral Anti-Xa Inhibitors in S. Aureus Bacteremia (PHASE4)
- The Intensive Care Platform Trial (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Low Molecular Weight Heparin CI brief — competitive landscape report
- Low Molecular Weight Heparin updates RSS · CI watch RSS
- Yangzhou University portfolio CI
Frequently asked questions about Low Molecular Weight Heparin
What is Low Molecular Weight Heparin?
Low Molecular Weight Heparin is a Small molecule drug developed by Yangzhou University.
Who makes Low Molecular Weight Heparin?
Low Molecular Weight Heparin is developed and marketed by Yangzhou University (see full Yangzhou University pipeline at /company/yangzhou-university).
Is Low Molecular Weight Heparin also known as anything else?
Low Molecular Weight Heparin is also known as Fraxiparine, tinzaparin, Innohep LEO pharmaceutical products, heparin, Nadroparin calcium.
What development phase is Low Molecular Weight Heparin in?
Low Molecular Weight Heparin is FDA-approved (marketed).
Related
- Manufacturer: Yangzhou University — full pipeline
- Also known as: Fraxiparine, tinzaparin, Innohep LEO pharmaceutical products, heparin, Nadroparin calcium
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing